KR20180030166A - 2-아미노-1,3,4-티아디아진 및 2-아미노-1,3,4-옥사디아진 기반 항진균제 - Google Patents

2-아미노-1,3,4-티아디아진 및 2-아미노-1,3,4-옥사디아진 기반 항진균제 Download PDF

Info

Publication number
KR20180030166A
KR20180030166A KR1020187004510A KR20187004510A KR20180030166A KR 20180030166 A KR20180030166 A KR 20180030166A KR 1020187004510 A KR1020187004510 A KR 1020187004510A KR 20187004510 A KR20187004510 A KR 20187004510A KR 20180030166 A KR20180030166 A KR 20180030166A
Authority
KR
South Korea
Prior art keywords
thiazin
amine
alkyl
butyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020187004510A
Other languages
English (en)
Korean (ko)
Inventor
그레헴 에듀워드 모리스 시브리
라스 조나스 말름스트렘
조안나 마리아 라르송
Original Assignee
에프2지 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프2지 리미티드 filed Critical 에프2지 리미티드
Publication of KR20180030166A publication Critical patent/KR20180030166A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020187004510A 2015-07-14 2016-07-14 2-아미노-1,3,4-티아디아진 및 2-아미노-1,3,4-옥사디아진 기반 항진균제 Withdrawn KR20180030166A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1512286.4A GB201512286D0 (en) 2015-07-14 2015-07-14 Chemical compounds
GB1512286.4 2015-07-14
PCT/GB2016/052132 WO2017009651A1 (en) 2015-07-14 2016-07-14 2-amino-1,3,4-thiadiazine and 2-amino-1,3,4-oxadiazine based antifungal agents

Publications (1)

Publication Number Publication Date
KR20180030166A true KR20180030166A (ko) 2018-03-21

Family

ID=54013916

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187004510A Withdrawn KR20180030166A (ko) 2015-07-14 2016-07-14 2-아미노-1,3,4-티아디아진 및 2-아미노-1,3,4-옥사디아진 기반 항진균제

Country Status (9)

Country Link
US (1) US20180201592A1 (enExample)
EP (1) EP3322705A1 (enExample)
JP (1) JP2018527316A (enExample)
KR (1) KR20180030166A (enExample)
CN (1) CN108368102A (enExample)
AU (1) AU2016293316A1 (enExample)
CA (1) CA2991684A1 (enExample)
GB (1) GB201512286D0 (enExample)
WO (1) WO2017009651A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2903161T3 (es) * 2017-04-12 2022-03-31 Momentum Bioscience Ltd Detección y definición de microorganismos mediante el uso del gen ILV3
CN108586273B (zh) * 2018-03-07 2019-12-10 江南大学 一种盐酸普萘洛尔的制备方法
CN120329218A (zh) * 2025-06-23 2025-07-18 富祥(山东)新材料有限公司 一种抗hiv病毒类药物中间体的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS428033Y1 (enExample) * 1966-11-05 1967-04-24
US3779736A (en) * 1971-01-04 1973-12-18 Gulf Research Development Co 1,3,4-thiadiazine herbicides
JPS49110696A (enExample) * 1973-03-10 1974-10-22
US4254259A (en) * 1978-11-02 1981-03-03 Indiana University Foundation 2-Amino-5-ethylovalyl-6H-1,3,4-thiadiazine oxime
JPS58177482A (ja) * 1982-04-10 1983-10-18 Mitsui Petrochem Ind Ltd 2,6−ジ−tert−ブチル−4−アシロキシメチルフエノ−ルの製法
AU2011276539A1 (en) * 2010-06-28 2013-02-07 President And Fellows Of Harvard College Compounds for the inhibition of cellular proliferation
WO2014182950A1 (en) * 2013-05-10 2014-11-13 Nimbus Apollo, Inc. Acc inhibitors and uses thereof

Also Published As

Publication number Publication date
AU2016293316A1 (en) 2018-01-25
US20180201592A1 (en) 2018-07-19
WO2017009651A1 (en) 2017-01-19
GB201512286D0 (en) 2015-08-19
CA2991684A1 (en) 2017-01-19
CN108368102A (zh) 2018-08-03
JP2018527316A (ja) 2018-09-20
EP3322705A1 (en) 2018-05-23

Similar Documents

Publication Publication Date Title
AU2009262241B2 (en) 1, 2 disubstituted heterocyclic compounds
JP6386035B2 (ja) 金属酵素阻害剤化合物
EP1802583A1 (de) Heterocyclische carbonylverbindungen
WO2003082787A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CZ20001623A3 (cs) Terapeuticky účinné látky na bázi nahrazení katecholu indazolovým bioisosterem v inhibitorech PDE4
CN1473154A (zh) 2,3-二氮杂萘酮衍生物
WO2005077948A1 (ja) 抗真菌作用複素環化合物
NZ569209A (en) Substituted imidazoles and their use as pesticides
KR20120129869A (ko) Mglur4 알로스테릭 강화제, 조성물 및 신경 기능이상을 치료하는 방법
US7173134B2 (en) Selective RXR ligands
TW201710236A (zh) 羧酸取代的(雜)芳環類衍生物及其製備方法和用途
JPWO2010007943A1 (ja) 含窒素複素環化合物
KR20110051226A (ko) Crf1 길항제로서의 피라졸로[5,1-b]옥사졸 유도체
WO2003057161A2 (en) BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
WO2005092304A2 (en) Antifungal agents
JP6062948B2 (ja) V1aアンタゴニストとしてのシクロヘキシル−4H,6H−5−オキサ−2,3,10b−トリアザ−ベンゾ[e]アズレン
KR20180030166A (ko) 2-아미노-1,3,4-티아디아진 및 2-아미노-1,3,4-옥사디아진 기반 항진균제
KR20250044684A (ko) 신경퇴행성 질환 치료용 (아자)스피로헵탄 유도체
KR20140022840A (ko) 당뇨병을 치료하기 위한 호르몬 감수성 리파제 저해제로서의 2급-하이드록시사이클로헥실 유도체
EP2688881B1 (en) New azaspirodecanone compounds as hsl inhibitors
KR20140011335A (ko) 아자스피로데카논 화합물
WO2020095912A1 (ja) ベンズイミダゾール誘導体
JP2001192386A (ja) 新規トリアゾール誘導体及びこれを有効成分とする抗真菌剤
US20090270363A1 (en) 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
US20250388592A1 (en) (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180213

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination